Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy

被引:10
|
作者
Shirai, K
Watanabe, K
Ma, ML
Wahed, MII
Inoue, M
Saito, Y
Suresh, PS
Kashimura, T
Tachikawa, H
Kodama, M
Aizawa, Y
机构
[1] Niigata Univ, Dept Clin Pharmacol, Niigata 9502081, Japan
[2] Niigata Univ, Sch Med, Dept Med 1, Niigata, Japan
关键词
angiotensin receptor blockade; heart failure; candesartan; angiotensin-II; dilated cardiomyopathy; transforming growth factor-beta 1; collagen-III;
D O I
10.1007/s11010-005-3446-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We examined effects of an angiotensin-II receptor blockers, candesartan cilexetil, in rats with dilated cardiomyopathy after autoimmune myocarditis. Candesartan cilexetil showed angiotensin-II blocking action in a dose-dependent manner in rats with dilated cardiomyopathy. Twenty-eight days after immunization, surviving Lewis rats were divided into four groups and given candesartan cilexetil at 0.05 mg/kg, 0.5 mg/kg or 5 mg/kg per day (Group-C0.05, n = 15, Group-C0.5, n = 15 and Group-C5, n = 15, respectively) or vehicle alone (Group-V, n = 15). After oral administration for 1 month, the left ventricular end-diastolic pressure and heart weight/body weight ratio were lower in Group-C0.05 (13.3 +/- 1.1 mmHg and 3.7 +/- 0.2 g/kg, respectively), in Group-C0.5 (8.0 +/- 0.9 mmHg and 3.3 +/- 0.1 g/kg, respectively) and in Group-C5 (5.5 +/- 1 mmHg and 3.1 +/- 0.1 g/kg, respectively) than in Group-V (13.5 +/- 1.0 mmHg and 3.8 +/- 0.2 g/kg, respectively). The area of myocardial fibrosis was also lower in Group-C0.05 (25 +/- 3%), in Group-C0.5 (20 3%), and in Group-C5 (12 +/- 1%) than in Group-V (32 +/- 4%). Furthermore, expressions of transforming growth factor-beta1 and collagen-III mRNA were suppressed in Group-C0.05 (349 +/- 23% and 395 +/- 22%, respectively), Group-C0.5 (292 +/- 81% and 364 +/- 42%, respectively) and in Group-C5 (204 +/- 63% and 259 +/- 33%, respectively) compared with those in Group-V (367 +/- 26% and 437 +/- 18%, respectively). These results suggest that candesartan cilexetil can improve the function of inefficient heart.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [1] Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy
    Ken Shirai
    Kenichi Watanabe
    Meilei Ma
    Mir I I Wahed
    Mikio Inoue
    Yuki Saito
    Palaniyandi Selvaraj Suresh
    Takeshi Kashimura
    Hitoshi Tachikawa
    Makoto Kodama
    Yoshifusa Aizawa
    [J]. Molecular and Cellular Biochemistry, 2005, 269 : 137 - 142
  • [2] Candesartan cilexetil: An angiotensin II receptor blocker
    Stoukides, CA
    McVoy, HJ
    Kaul, AF
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1287 - 1298
  • [3] Angiotensin II receptor blocker: Candesartan cilexetil
    Inada, Y
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 35P - 35P
  • [4] Candesartan cilexetil: An angiotensin II-receptor blocker
    See, S
    Stirling, AL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (08) : 739 - 746
  • [5] Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy
    Sukumaran, Vijayakumar
    Watanabe, Kenichi
    Veeraveedu, Punniyakoti T.
    Thandavarayan, Rajarajan A.
    Gurusamy, Narasimman
    Ma, Meilei
    Yamaguchi, Ken'ichi
    Suzuki, Kenji
    Kodama, Makoto
    Aizawa, Yoshifusa
    [J]. HYPERTENSION RESEARCH, 2010, 33 (07) : 695 - 702
  • [6] Telmisartan, an angiotensin-II receptor blocker ameliorate cardiac remodeling in rats with dilated cardiomyopathy
    Sukumaran, V.
    Watanabe, K.
    Ma, M.
    Thandavarayan, R.
    Azrozal, W.
    Sari, F.
    Shimazaki, H.
    Kobayashi, Y.
    [J]. CARDIOVASCULAR RESEARCH, 2010, 87 : S133 - S133
  • [7] Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy
    Vijayakumar Sukumaran
    Kenichi Watanabe
    Punniyakoti T Veeraveedu
    Rajarajan A Thandavarayan
    Narasimman Gurusamy
    Meilei Ma
    Ken'ichi Yamaguchi
    Kenji Suzuki
    Makoto Kodama
    Yoshifusa Aizawa
    [J]. Hypertension Research, 2010, 33 : 695 - 702
  • [8] Effects of angiotensin II receptor blocker in hamsters with dilated cardiomyopathy
    Fukud, Yoshizo
    Isomura, Takumi
    Nagao, Tomoko
    Shirahata, Miki
    Ikeda, Hironobu
    Furukawa, Shigenori
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 262P - 262P
  • [9] Angiotensin II receptor antagonists: Candesartan cilexetil
    Naka, T
    Kubo, K
    Nishikawa, K
    Inada, Y
    Furukawa, Y
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (12): : 1261 - 1275
  • [10] Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy
    Watanabe, K
    Juan, W
    Narasimman, G
    Ma, ML
    Inoue, M
    Saito, Y
    Wahed, MI
    Nakazawa, M
    Hasegawa, G
    Naito, M
    Tachikawa, H
    Tanabe, N
    Kodama, M
    Aizawa, Y
    Yamamoto, T
    Yamaguchi, K
    Takahashi, T
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 : S93 - S97